Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
PaperCitations, authors & open-access status
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 126 citations, 2018 year and closed oa status.
126
Citations
2018
Year
closed
OA Status